Populational equilibrium through exosome-mediated Wnt signaling in tumor progression of diffuse large B-cell lymphoma

被引:102
作者
Koch, Raphael [1 ]
Demant, Martin [1 ]
Aung, Thiha [1 ]
Diering, Nina [1 ]
Cicholas, Anna [1 ]
Chapuy, Bjoern [2 ]
Wenzel, Dirk [3 ]
Lahmann, Marlen [1 ]
Guentsch, Annemarie [1 ]
Kiecke, Christina [1 ]
Becker, Sabrina [1 ]
Hupfeld, Timo [1 ]
Venkataramani, Vivek [1 ]
Ziepert, Marita [4 ]
Opitz, Lennart [5 ]
Klapper, Wolfram [6 ,7 ]
Truemper, Lorenz [1 ]
Wulf, Gerald G. [1 ]
机构
[1] Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany
[4] Inst Med Informat Stat & Epidemiol, Leipzig, Germany
[5] Funct Genom Ctr Zurich, Zurich, Switzerland
[6] Hematopathol Sect, Kiel, Germany
[7] Lymph Node Registry, Kiel, Germany
关键词
ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; DRUG EFFLUX CAPACITY; BETA-CATENIN; SIDE POPULATION; ELDERLY-PATIENTS; TRANSPORTER A3; GROWTH-FACTORS; CANCER-CELLS; IN-VIVO;
D O I
10.1182/blood-2013-08-523886
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumors are composed of phenotypically heterogeneous cell populations. The non-genomic mechanisms underlying transitions and interactions between cell populations are largely unknown. Here, we show that diffuse large B-cell lymphomas possess a self-organized infrastructure comprising side population (SP) and non-SP cells, where transitions between clonogenic states are modulated by exosome-mediated Wnt signaling. DNA methylation modulated SP-non-SP transitions and was correlated with the reciprocal expressions of Wnt signaling pathway agonist Wnt3a in SP cells and the antagonist secreted frizzled-related protein 4 in non-SP cells. Lymphoma SP cells exhibited autonomous clonogenicity and exported Wnt3a via exosomes to neighboring cells, thus modulating population equilibrium in the tumor.
引用
收藏
页码:2189 / 2198
页数:10
相关论文
共 50 条
[31]   Diffuse Large B-Cell Lymphoma: Current Treatment Approaches [J].
Nastoupil, Loretta J. ;
Rose, Adam C. ;
Flowers, Christopher R. .
ONCOLOGY-NEW YORK, 2012, 26 (05) :488-495
[32]   Prevention of CNS relapse in diffuse large B-cell lymphoma [J].
Kridel, Robert ;
Dietrich, Pierre-Yves .
LANCET ONCOLOGY, 2011, 12 (13) :1258-1266
[33]   Metadherin Contributes to the Pathogenesis of Diffuse Large B-cell Lymphoma [J].
Ge, Xueling ;
Lv, Xiao ;
Feng, Lili ;
Liu, Xiaoqian ;
Gao, Junming ;
Chen, Na ;
Wang, Xin .
PLOS ONE, 2012, 7 (06)
[34]   ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma [J].
Dabaja, Bouthaina S. ;
Advani, Ranjana ;
Hodgson, David C. ;
Dhakal, Sughosh ;
Flowers, Christopher R. ;
Ha, Chul S. ;
Hoppe, Bradford S. ;
Mendenhall, Nancy P. ;
Metzger, Monika L. ;
Plastaras, John P. ;
Roberts, Kenneth B. ;
Shapiro, Ronald ;
Smith, Sonali M. ;
Terezakis, Stephanie A. ;
Winkfield, Karen M. ;
Younes, Anas ;
Constine, Louis S. .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (06) :610-620
[35]   Current therapeutic strategies for diffuse large B-cell lymphoma [J].
Pfreundschuh, M. .
INTERNIST, 2016, 57 (03) :214-+
[36]   Treatment strategies for patients with diffuse large B-cell lymphoma [J].
Poletto, Stefano ;
Novo, Mattia ;
Paruzzo, Luca ;
Frascione, Pio Manlio Mirko ;
Vitolo, Umberto .
CANCER TREATMENT REVIEWS, 2022, 110
[37]   Clinical features of diffuse large B-cell lymphoma with polyploidy [J].
Shimono, Joji ;
Miyoshi, Hiroaki ;
Seto, Masao ;
Teshima, Takanori ;
Ohshima, Koichi .
PATHOLOGY INTERNATIONAL, 2017, 67 (01) :17-23
[38]   Novel Targeted Therapies in Diffuse Large B-Cell Lymphoma [J].
Mehta-Shah, Neha ;
Younes, Anas .
SEMINARS IN HEMATOLOGY, 2015, 52 (02) :126-137
[39]   New developments in the management of diffuse large B-cell lymphoma [J].
Habermann, Thomas M. .
HEMATOLOGY, 2012, 17 :S93-S97
[40]   Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma [J].
Perry, Anamarija M. ;
Mitrovic, Zdravko ;
Chan, Wing C. .
CANCER CONTROL, 2012, 19 (03) :214-226